LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Clinical trial NCT05798923 · RECRUITING
Trial details
- NCT number
- NCT05798923
- Sponsor
- OrphAI Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2027-07-16
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.